(NYSE: ALB) Albemarle's forecast annual revenue growth rate of 8.2% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.36%.
Albemarle's revenue in 2026 is $5,142,733,000.On average, 26 Wall Street analysts forecast ALB's revenue for 2026 to be $679,507,070,520, with the lowest ALB revenue forecast at $542,215,059,220, and the highest ALB revenue forecast at $864,762,900,360. On average, 24 Wall Street analysts forecast ALB's revenue for 2027 to be $718,514,500,340, with the lowest ALB revenue forecast at $587,468,391,700, and the highest ALB revenue forecast at $972,003,870,560.
In 2028, ALB is forecast to generate $771,074,360,460 in revenue, with the lowest revenue forecast at $611,273,530,140 and the highest revenue forecast at $983,906,439,780.